Nüsing RM et al. |
Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. |
2001 |
Clin. Pharmacol. Ther. |
pmid:11673754
|
Martinuzzo ME et al. |
Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies. |
2001 |
Br. J. Haematol. |
pmid:11564073
|
McConnell JP et al. |
Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke. |
2001 |
Neurosci. Lett. |
pmid:11684346
|
Nakamura H et al. |
Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis. |
2001 Nov-Dec |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:11993724
|
Bruno A et al. |
Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients. |
2002 |
Stroke |
pmid:11779889
|
Saareks V et al. |
Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. |
2002 |
Pharmacol. Toxicol. |
pmid:12403056
|
Kudolo GB et al. |
Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. |
2002 |
Thromb. Res. |
pmid:12590952
|
Sinzinger H |
Comments on "Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications". |
2002 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12445490
|
Eikelboom JW et al. |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. |
2002 |
Circulation |
pmid:11940542
|
Hayashi M et al. |
The levels of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy. |
2002 |
Acta Obstet Gynecol Scand |
pmid:11966476
|